Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  770 results for ""Abatacept""

Your Filters

Publication : plos one
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab.

  • Authors : Talmon M; Department of Health Sciences, School of Medicine, University of Piemonte Orientale, Novara, Italy.; Percio M

Subjects: Abatacept*/Abatacept*/Abatacept*/pharmacology ; Abatacept*/Abatacept*/Abatacept*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

  • Source: PloS one [PLoS One] 2023 Mar 06; Vol. 18 (3), pp. e0282564. Date of Electronic Publication: 2023 Mar 06 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis.

Subjects: Abatacept/Abatacept/Abatacept/*pharmacology ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*pharmacology ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

  • Source: PloS one [PLoS One] 2020 Aug 06; Vol. 15 (8), pp. e0237143. Date of Electronic Publication: 2020 Aug 06 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis.

  • Authors : Huoponen S; University of Helsinki, Helsinki, Finland.; ESiOR Oy, Kuopio, Finland.

Subjects: Abatacept*/Abatacept*/Abatacept*/economics ; Abatacept*/Abatacept*/Abatacept*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/economics

  • Source: PloS one [PLoS One] 2019 Jul 24; Vol. 14 (7), pp. e0220142. Date of Electronic Publication: 2019 Jul 24 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research.

  • Authors : Maeda S; Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.; Osaga S

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

  • Source: PloS one [PLoS One] 2019 Nov 20; Vol. 14 (11), pp. e0215192. Date of Electronic Publication: 2019 Nov 20 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study.

  • Authors : Balandraud N; Rheumatology 1 or 2, IML, AP-HM, 270 Boulevard de Sainte Marguerite, Marseilles, France.; INSERM UMRs 1097, Aix-Marseille University, 163 Avenue de Luminy, Marseilles, France.

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

  • Source: PloS one [PLoS One] 2017 Feb 15; Vol. 12 (2), pp. e0171623. Date of Electronic Publication: 2017 Feb 15 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge.

  • Authors : Sisteré-Oró M; IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.; Vergara-Alert J

Subjects: Abatacept*/Abatacept*/Abatacept*/genetics ; Abatacept*/Abatacept*/Abatacept*/immunology ; Abatacept*/Abatacept*/Abatacept*/pharmacology

  • Source: PloS one [PLoS One] 2019 Mar 01; Vol. 14 (3), pp. e0212431. Date of Electronic Publication: 2019 Mar 01 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy.

Subjects: Abatacept/Abatacept/Abatacept/*pharmacology ; CD4-Positive T-Lymphocytes/CD4-Positive T-Lymphocytes/CD4-Positive T-Lymphocytes/*immunology ; Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/*immunology

  • Source: PloS one [PLoS One] 2016 Apr 07; Vol. 11 (4), pp. e0152315. Date of Electronic Publication: 2016 Apr 07 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab.

  • Authors : Provan SA; Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.; Berg IJ

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use

  • Source: PloS one [PLoS One] 2015 Jun 26; Vol. 10 (6), pp. e0130709. Date of Electronic Publication: 2015 Jun 26 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry.

  • Authors : Lin CT; Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan.; Huang WN

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy ; Pharmaceutical Preparations/Pharmaceutical Preparations/Pharmaceutical Preparations/*chemistry

  • Source: PloS one [PLoS One] 2021 Apr 30; Vol. 16 (4), pp. e0250877. Date of Electronic Publication: 2021 Apr 30 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Intranasal administration of abatacept enhances IL-35+ and IL-10+ producing Bregs in lung tissues of ovalbumin-sensitized asthmatic mice model.

Subjects: LUNGS; REGULATORY B cells; INTRANASAL administration

  • Source: PLoS ONE; 9/6/2022, Vol. 17 Issue 9, p1-14, 14p

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  770 results for ""Abatacept""